CHRISTY DRUMMOND: Open Payments
NPI 1891412292 · WARREN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,135 in 106 payments from 15 companies in 2025. Trend: 2023 $1,373 · 2024 $1,568 · 2025 $2,135
Food & beverage: $2,135
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 31 | $860 |
| ABBVIE INC. | 21 | $300 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $200 |
| Otsuka America Pharmaceutical, Inc. | 8 | $172 |
| Supernus Pharmaceuticals, Inc. | 13 | $166 |
| Neurocrine BioSciences, Inc. | 4 | $88 |
| E.R. Squibb & Sons, L.L.C. | 3 | $62 |
| Axsome Therapeutics, Inc. | 3 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $47 |
| Corium, LLC | 2 | $44 |
Products named: FANAPT, VRAYLAR, REXULTI, CAPLYTA, Qelbree, INGREZZA, COBENFY, Auvelity.
Industry payments across OH — which companies pay providers there.
